Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs

Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes

Islet-on-a-chip technology streamlines diabetes research

Injectable sponge-like gel enhances the quantity and quality of T-cells